Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters

被引:3
|
作者
You, Helena [1 ]
Sanli, Yasemin [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
关键词
Ga-68-DOTATATE; neuroendocrine tumors; PET/CT; point-spread function; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; TIME-OF-FLIGHT; NEUROENDOCRINE TUMORS; F-18-FDG PET/CT; MANAGEMENT; HETEROGENEITY; DIAGNOSIS; IN-111-DTPA-OCTREOTIDE; DOSIMETRY;
D O I
10.2214/AJR.18.21067
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the impact of point-spread function (PSI) reconstruction and lesion size on Ga-68-tetraazacyclododecanetetraacetic acid-DPhel-Tyr3-octreotate (DOTATATE) PET/CT quantitative parameters. MATERIALS AND METHODS. A total of 38 patients with 42 Ga-68-DOATATE PET/CT studies and 125 lesions were included. Scans were reconstructed with and without PSF modulation. For each lesion, the maximum standardized uptake value (SUVmax) and peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV), total lesion somatostatin avidity, and tumor somatostatin receptor expression heterogeneity using the AUC method were measured. Intraclass correlation coefficient (ICC) and Bland-Altman analyses were used to compare PSF and non-PSF values. A subgroup analysis was performed to determine the impact of lesion size. RESULTS. Of the 125 lesions, 51 were in the liver, 31 in lymph nodes, 17 in bone, eight in pancreas, four in lung, and 14 in other sites. The ICCs between PSF and non-PSF values were excellent for SUVmax, SUVpeak, MTV, and total lesion somatostatin avidity (ICC = 0.97-0.99), and the ICC was good for tumor somatostatin receptor expression heterogeneity (ICC = 0.81). Comparison of PSF with non-PSF values showed a bias (mean percentage change +/- SD) of 27.5% +/- 14.7% for SUVmax, 15.5% +/- 9.5% for SUVpeak, -18.6% +/- 37.6% for MTV, 0.8% +/- 28.1% for total lesion somatostatin avidity, and -7.1% +/- 11.0% for tumor somatostatin receptor expression heterogeneity. Comparison of PSF with non-PSF values for lesions less than 2 cm (n = 75) showed corresponding biases greater than those for lesions 2 cm or larger (n = 50). CONCLUSION. PSF reconstruction effected higher values for SUVmax and SUVpeak, produced decreased values for tumor somatostatin receptor expression heterogeneity, and had a variable effect on MTV and total lesion somatostatin avidity depending on lesion size.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 50 条
  • [1] 68Ga-DOTATATE PET/CT Imaging in Carotid Body Tumor
    Gayana, Shankaramurthy
    Mittal, Bhagwant Rai
    Bhattacharya, Anish
    Radotra, Bishan Dass
    Gupta, Ashok K.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (04) : E191 - E193
  • [2] 68Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma
    Krokhmal, Aleksandra A.
    Kwatra, Neha
    Drubach, Laura
    Weldon, Christopher B.
    Janeway, Katherine A.
    DuBois, Steven G.
    Kamihara, Junne
    Voss, Stephan D.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [3] 68Ga-DOTATATE PET/CT in Pituitary Carcinoma
    Kaya, Gursan
    Soydas Turan, Basak
    Dagdelen, Selcuk
    Berker, Mustafa
    Tuncel, Murat
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : 996 - 998
  • [4] 68Ga-DOTATATE PET-CT imaging in carotid body paragangliomas
    Simsek, Duygu Has
    Sanli, Yasemin
    Kuyumcu, Serkan
    Basaran, Bora
    Mudun, Ayse
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (04) : 297 - 301
  • [5] 68Ga-DOTATATE PET/CT imaging in endogenous hyperinsulinemic hypoglycemia: A tertiary endocrine centre experience
    Shah, Ravikumar
    Sehemby, Manjeetkaur
    Garg, Robin
    Purandare, Nilendu
    Hira, Priya
    Mahajan, Abhishek
    Lele, Vikram
    Malhotra, Gaurav
    Verma, Priyanka
    Rojekar, Amey
    Dalvi, Abhay
    Uchino, Shinya
    Rastogi, Shivam
    Lila, Anurag
    Patil, Virendra
    Shah, Nalini
    Bandgar, Tushar
    CLINICAL ENDOCRINOLOGY, 2022, 96 (02) : 190 - 199
  • [6] The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Goeke, Burkhard
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (11) : 1686 - 1692
  • [7] Synchronous Endometrial Cancer Detected on 68Ga-DOTATATE PET/CT
    Mohammadinejad, Payam
    Kim, Alex
    Koshevarova, Victoria
    Murphy, Micah
    Shagun, F. N. U.
    Bhargava, Peeyush
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 96 - 97
  • [8] Clinical impact of 68Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer
    Tuncel, Murat
    Kilickap, Saadettin
    Suslu, Nilda
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (09) : 663 - 674
  • [9] 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor
    Komek, Halil
    Gundogan, Cihan
    Can, Canan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (05) : E290 - E292
  • [10] A Case Report: Insulinoma in a Military Pilot Detected by 68Ga-Dotatate PET/CT
    Larose, Lisa D.
    Vroman, Penny J.
    Musick, Sierra R.
    Beauvais, Alexis A.
    MILITARY MEDICINE, 2020, 185 (9-10) : E1887 - E1890